Sleep and Performance

This recruiting clinical trial at the University of Washington is investigating how the brain's waste-clearance system — the glymphatic system — is affected by poor sleep in younger adults. The glymphatic system flushes metabolic byproducts from the brain primarily during deep, slow-wave sleep, and disruptions to this process have been linked to cognitive decline and neurodegenerative risk. The study uses novel, contrast-free MRI techniques to visualize glymphatic function without the need for injected dye, allowing repeated, safe imaging across multiple sessions. A key experimental intervention is the Wireless Interface Sensor Pod (WISP), a wearable headband that both monitors brain waves and delivers transcranial electrical stimulation (TES) to enhance slow-wave sleep architecture. Researchers will test whether the WISP can restore glymphatic clearance and memory performance after sleep has been experimentally disrupted. Participants complete four weekly MRI sessions paired with cognitive assessments, enabling within-person comparisons across sleep conditions. The study is notable for pairing a cutting-edge noninvasive neuroimaging biomarker with a real-world wearable intervention, bridging mechanistic brain science and translatable sleep technology.

• No results yet — trial is currently recruiting (as of 2026-05-27); all findings below are pre-specified hypotheses, not outcomes.
• The study predicts that contrast-free MRI will detect region-specific glymphatic impairment in brain areas linked to memory consolidation following poor sleep.
• The primary intervention hypothesis is that WISP-mediated transcranial electrical stimulation targeting slow-wave sleep will partially rescue glymphatic clearance and memory performance compared to unassisted poor-sleep nights.

This is a prospective, within-subject interventional pilot trial enrolling younger adults at the University of Washington's Diagnostic Imaging Sciences Center. Each participant attends four weekly in-person visits (~2 hours each), comprising approximately 1 hour of contrast-free MRI and 1 hour of standardized cognitive testing per visit. The intervention arm uses the WISP headband — a closed-loop device combining EEG-based slow-wave sleep monitoring with transcranial electrical stimulation — across designated sleep conditions. The repeated-measures design allows each participant to serve as their own control, with sleep quality and glymphatic outcomes compared across normal-sleep and sleep-disruption conditions.

Because the trial is still recruiting, no efficacy or safety data are yet available, and all mechanistic claims remain hypothetical at this stage — confidence in any specific finding is low. The sample appears limited to younger adults, which constrains generalizability to older populations where glymphatic decline and neurodegenerative risk are most clinically relevant. The 4-week, 4-visit design may be insufficient to capture cumulative or chronic effects of sleep disruption on glymphatic function. A natural next experiment would be a larger, sham-controlled, multi-night polysomnography study in middle-aged and older adults to determine whether WISP-driven slow-wave enhancement produces durable improvements in glymphatic clearance biomarkers.

This trial sits at the mechanistic core of the sleep-biology corpus assembled here and most directly extends the glymphatic framework documented in [§47] and [§43], both of which link obstructive sleep apnea severity to DTI-ALPS-measured glymphatic impairment — the present study applies analogous noninvasive neuroimaging logic to experimentally induced sleep disruption rather than clinical OSA. It parallels [§132] (Enhancing Slow Wave Sleep in Depression), which also uses targeted slow-wave augmentation as a therapeutic lever, though in a psychiatric rather than healthy-adult population and without the wearable TES component. The circadian-regulation angle invoked by glymphatic timing connects loosely to [§44] (CLOCK-BMAL1 circadian regulation), which provides the upstream molecular context for why slow-wave sleep windows are biologically gated. Additionally, [§133] (Sleep, Light, Circadian, Central Oxidative Stress) parallels this work by examining how sleep-circadian misalignment generates oxidative neural stress, a plausible downstream consequence of the glymphatic failure this trial aims to prevent.

• Association between obstructive sleep apnea severity and glymphatic-related DTI-ALPS alterations in newly diagnosed, Drug-Naïve Alzheimer's disease
  Directly measures glymphatic function via DTI-ALPS in a sleep-disordered population, providing an empirical benchmark for the contrast-free MRI glymphatic signals this trial aims to validate in healthy adults with induced sleep disruption.
• Association between obstructive sleep apnea severity and glymphatic-related DTI-ALPS alterations in newly diagnosed, Drug-Naïve Alzheimer's disease
  Uses the same OSA-glymphatic-DTI framework and overlaps substantially with [id=47]; comparing the two helps readers triangulate how glymphatic MRI signals scale with sleep disruption severity across clinical and experimental contexts.
• Enhancing Slow Wave Sleep in Depression
  Tests slow-wave sleep enhancement as a neurotherapeutic intervention in a depressed cohort — a direct methodological parallel that lets readers assess whether WISP-style SWS augmentation generalizes beyond mood disorders to glymphatic and memory outcomes.
• The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting
  Provides the upstream molecular circadian machinery (CLOCK-BMAL1) that governs the timing of glymphatic activity, giving mechanistic depth to why slow-wave sleep timing — not just duration — is the critical variable this trial manipulates.
• Sleep, Light, Circadian, Central Oxidative Stress
  Examines how sleep-circadian disruption drives central oxidative stress, offering a complementary neurochemical outcome pathway to the glymphatic-clearance model tested here and raising the question of whether WISP-improved SWS also attenuates oxidative markers.